bismuth has been researched along with Diarrhea in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (47.52) | 18.7374 |
1990's | 18 (17.82) | 18.2507 |
2000's | 18 (17.82) | 29.6817 |
2010's | 12 (11.88) | 24.3611 |
2020's | 5 (4.95) | 2.80 |
Authors | Studies |
---|---|
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
Fan, X; Lu, D; Yao, G | 1 |
Agboatwalla, M; Bowen, A; Brum, J; Pitz, A; Plikaytis, B; Salahuddin, S | 1 |
Rubin, DT; Wolf, CH; Wolf, DC | 1 |
Balan, G; Brum, JM; Gibb, RD; Ramsey, DL; Yacyshyn, BR | 1 |
Janssens, L; Ji, H; Khanna, S | 1 |
Chande, N; Kafil, TS; MacDonald, JK; McDonald, JW; Nguyen, TM; Patton, PH | 1 |
Gan, HY; Huang, YM; Peng, TL; Su, KH; Yang, RJ; Yao, LY; Zhao, LL | 1 |
Chalkias, S; Edwards, MR; Koulinska, I; Riester, K | 1 |
Goldman, RD | 1 |
Heather, CS | 1 |
Cartowski, J; Dart, A; Gupta, A; Gupta, S; Nelson, C; Poddar, A; Ravi, BS; Sheele, J; Stashko, E | 1 |
Jang, BI; Kim, KO; Kim, SB; Kim, TN; Lee, SH | 1 |
Giddings, SL; Leung, DT; Stevens, AM | 1 |
Sökeland, J | 1 |
Agafonova, NA; Aldiiarova, MA; D'iachkoava, AV; Davletshina, IV; Gioeva, IZ; Iakovenko, AV; Iakovenko, EP; Ivanov, AN; Kolganova, AV; Nazarbekova, RS; Ovchinnikova, NI; Pokhal'skaia, OIu; Popova, EV; Prianishnikova, AS | 1 |
Redfield, D; Singh, E | 1 |
Banks, MR; Kent, AJ | 1 |
Tack, J | 1 |
Wenzl, HH | 1 |
Chande, N; MacDonald, JK; McDonald, JW | 5 |
ELIACHAR, E | 1 |
BRETON, A; DUPUIS, C; LEFEBVRE, P | 1 |
BORNICHE, P; CANLORBE, P | 1 |
VARGASMAGNE, R | 1 |
SATOMI, M | 1 |
CASTELLAN, M; PORTAL, A | 1 |
GOIFFON, B; TOULET, J | 1 |
Delgado, B; Delgado, J; Fich, A; Odes, S | 1 |
DuPont, HL | 2 |
DuPont, HL; Koo, HL | 1 |
Wicki, O | 1 |
Turner, AC | 1 |
Weiss, BD | 2 |
Barriere, SL; Kapusnik, JE | 1 |
Estes, MK; Gentry, LO; Graham, DY | 1 |
Feldman, M | 1 |
McIntyre, RV | 1 |
Hüttel, E | 1 |
Stek, M | 1 |
Levine, RA | 1 |
Scott, D | 1 |
Ackerman, PB; DuPont, HL; Ericsson, CD; Evans, DG; Evans, DJ; Pickering, LK; Sullivan, P; Tjoa, WS; Vollet, JJ | 1 |
Gorbach, SL | 2 |
Arndt, WF; Burns, JM | 1 |
Marsh, AP; McPhee, MS | 1 |
DuPont, HL; Ericsson, CD; Pickering, LK; Sullivan, P | 1 |
Schiller, LR | 2 |
Rampal, P; Scarpignato, C | 1 |
Axon, AT; Ireland, A; Rooprams, PD; Smith, MJ | 1 |
de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ; van Unnik, AJ | 1 |
Scott, BB | 1 |
Ericsson, CD | 1 |
Ahsan, K; Hadjiyane, C; Karakurum, A; Mohammed, I; Nawaz, A; Pellecchia, C | 1 |
Shlim, DR | 1 |
Chowdhury, HR; Faruque, SM; Lescano, AG; Rahman, A; Sack, RB; Yunus, M; Zaman, K | 1 |
Bruzzese, E; Guarino, A | 1 |
Fang, XC; Hu, PJ; Li, ZS; Lu, H; Lu, XH; Xiao, SD; Zhang, DZ | 1 |
Kollaritsch, H; Rendi-Wagner, P | 1 |
Bhathal, P; Gibson, P; Tagkalidis, P | 1 |
Ackerman, PB; DuPont, HL; Haynes, G; Pickering, LK; Sullivan, P | 1 |
Annexton, M | 1 |
Palmas, S | 1 |
Castellion, AW; Goldenberg, MM; Honkomp, LJ | 1 |
Keystone, JS; Tellier, R | 1 |
Farthing, MJ | 1 |
Raedsch, R | 1 |
Cruz Luna, A; DuPont, HL; DuPont, MW; Ericsson, CD; Flores Sanchez, J; Mathewson, JJ; Mendiola Gomez, J | 1 |
Holtz, TH; Nettleman, MD | 1 |
Hoffman, RS; Mendelowitz, PC; Weber, S | 1 |
Hänninen, ML | 1 |
Balm, TK; DuPont, HL; Ericsson, CD; Helminger, A; Mathewson, JJ; Steffen, R; Witassek, F; Wolff, K | 1 |
Imura, N; Naganuma, A; Satoh, M | 1 |
Umeki, S | 1 |
DuPont, HL; Helminger, A; Heusser, R; Manhart, MD; Schär, M; Steffen, R; Witassek, F | 1 |
Bitsura, JA; de la Cabada, FJ; DuPont, HL; DuPont, MW; Ericsson, CD; Johnson, PC | 1 |
Kreider, S; Lange, WR | 1 |
Du Pont, HL | 1 |
Graham, DY | 1 |
Bitsura, JA; DuPont, HL; Ericsson, CD; Johnson, PC; Morgan, DR; Wood, LV | 1 |
Jarriau, P; Niaudet, P; Rey, J; Schmitz, J; Schweisguth, O | 1 |
Kühn, A | 1 |
Clement, D; Gisselbrecht, H; Monange, C | 1 |
Calcagnini, G; Fusconi, A | 1 |
Négret, JP | 1 |
31 review(s) available for bismuth and Diarrhea
Article | Year |
---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Dietary Supplements; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Probiotics; Treatment Outcome | 2023 |
Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.
Topics: Bismuth; Communicable Diseases; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 2021 |
Interventions for treating collagenous colitis.
Topics: Bismuth; Boswellia; Budesonide; Cholestyramine Resin; Chronic Disease; Colitis, Collagenous; Diarrhea; Glucocorticoids; Humans; Mesalamine; Organometallic Compounds; Plant Extracts; Prednisolone; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2017 |
Travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Diarrhea; Diet; Fluid Therapy; Humans; Organometallic Compounds; Salicylates; Thiorphan; Travel-Related Illness | 2015 |
Traveler's Diarrhea.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antidiarrheals; Arthritis, Reactive; Bismuth; Dehydration; Diarrhea; Female; Fluid Therapy; Foodborne Diseases; Guillain-Barre Syndrome; Humans; Immunocompromised Host; Irritable Bowel Syndrome; Organometallic Compounds; Pregnancy; Probiotics; Risk Factors; Salicylates; Travel; Travel Medicine; Vaccines; Waterborne Diseases | 2016 |
Prophylaxis for travelers' diarrhea.
Topics: Antibiotic Prophylaxis; Antidiarrheals; Bismuth; Diarrhea; Disinfection; Fluid Therapy; Food Contamination; Food Microbiology; Humans; Hygiene; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology | 2009 |
Pharmacological management of diarrhea.
Topics: Anti-Infective Agents; Antidiarrheals; Bismuth; Calcium Channel Blockers; Calmodulin; Chloride Channels; Cholestyramine Resin; Diarrhea; Fluid Therapy; Humans; Narcotics; Neprilysin; Receptors, sigma; Serotonin Antagonists; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2010 |
Functional diarrhea.
Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Bismuth; Carbon; Cholestyramine Resin; Chronic Disease; Clonidine; Diarrhea; Humans; Octreotide; Organometallic Compounds; Oxides; Probiotics; Receptors, Opioid; Salicylates; Serotonin 5-HT3 Receptor Antagonists; Thiorphan | 2012 |
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections; Biopsy; Bismuth; Blood Cell Count; Blood Chemical Analysis; Body Water; Breath Tests; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Endoscopy, Gastrointestinal; Feces; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Fistula; Intestinal Mucosa; Intestines; Ion Transport; Malabsorption Syndromes; Medical History Taking; Mesalamine; Organometallic Compounds; Physical Examination; Postoperative Complications; Prednisolone; Salicylates; Sodium; Tumor Necrosis Factor-alpha | 2012 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Diarrhea; Humans; Organometallic Compounds; Salicylates | 2003 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Collagen; Diarrhea; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2003 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Collagen; Diarrhea; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2004 |
Microscopic colitis.
Topics: Antacids; Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis; Colon; Colonoscopy; Diarrhea; Humans | 2004 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Collagen; Diarrhea; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2005 |
Travellers' diarrhoea: contemporary approaches to therapy and prevention.
Topics: Anti-Bacterial Agents; Antidiarrheals; Azithromycin; Bismuth; Campylobacter; Clinical Trials as Topic; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; Food Microbiology; Humans; Hygiene; Organometallic Compounds; Rifamycins; Rifaximin; Salicylates; Shigella; Travel; Water Microbiology | 2006 |
Current and future developments in travelers' diarrhea therapy.
Topics: Bismuth; Diarrhea; Fluid Therapy; Humans; Organometallic Compounds; Probiotics; Rifamycins; Rifaximin; Risk Factors; Salicylates; Travel | 2006 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis, Collagenous; Diarrhea; Humans; Organometallic Compounds; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2006 |
Traveler's diarrhea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Campylobacter Infections; Diarrhea; Diet; Dysentery, Bacillary; Escherichia coli Infections; Fluid Therapy; Giardiasis; Humans; Intestines; Organometallic Compounds; Risk; Salicylates; Salmonella Infections; Time Factors; Travel; Vaccination; Vibrio Infections; Vibrio parahaemolyticus | 1984 |
Review article: anti-diarrhoeal pharmacology and therapeutics.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Agonists; Animals; Antidiarrheals; Berberine; Biological Transport; Bismuth; Chloride Channels; Codeine; Diarrhea; Fluid Therapy; Gastrointestinal Motility; Humans; Lithium; Morphine; Narcotics; Niacin; Somatostatin | 1995 |
Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Topics: Anti-Bacterial Agents; Antibiosis; Antidiarrheals; Bismuth; Clinical Trials as Topic; Diarrhea; Feeding Behavior; Fluid Therapy; Food Microbiology; Humans; Lactobacillus; Organometallic Compounds; Salicylates; Travel; Water Microbiology; Water Supply | 1995 |
Traveler's diarrhea.
Topics: Antibiotic Prophylaxis; Behavior Therapy; Bismuth; Diagnosis, Differential; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel; Vaccines | 1999 |
Microscopic colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Celiac Disease; Colitis; Colon; Diarrhea; Female; Humans; Male | 2002 |
What to do about traveller's diarrhoea.
Topics: Acute Disease; Anti-Bacterial Agents; Bismuth; Chronic Disease; Diarrhea; Fluid Therapy; Humans; Probiotics; Protozoan Infections; Travel | 2002 |
[Therapy of acute and chronic diarrhea in adults. I].
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Antidiarrheals; Antiemetics; Astringents; Bismuth; Chronic Disease; Diarrhea; Humans; Middle Aged; Parasympatholytics; Tannins | 1979 |
Prevention of traveler's diarrhea.
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Food Microbiology; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology; Water Supply | 1992 |
Review article: prevention and treatment of travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Diet; Fluid Therapy; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel | 1991 |
[Bismuth therapy in gastroenterology].
Topics: Bismuth; Diarrhea; Gastritis; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer | 1991 |
Bismuth therapy in gastrointestinal diseases.
Topics: Bismuth; Campylobacter; Chemical Phenomena; Chemistry; Diarrhea; Humans; Peptic Ulcer | 1990 |
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
Topics: Adolescent; Adult; Bismuth; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Humans; Middle Aged; Organometallic Compounds; Salicylates | 1987 |
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bismuth; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Diarrhea, Infantile; Drug Combinations; Dysentery, Amebic; Dysentery, Bacillary; Escherichia coli Infections; Giardiasis; Humans; Infant; Kaolin; Loperamide; Narcotics; Organometallic Compounds; Parasympatholytics; Pectins; Salicylates; Salmonella Infections; Travel | 1985 |
26 trial(s) available for bismuth and Diarrhea
Article | Year |
---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Effect of Bismuth Subsalicylate vs Placebo on Use of Antibiotics Among Adult Outpatients With Diarrhea in Pakistan: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antidiarrheals; Antimicrobial Stewardship; Bismuth; Diarrhea; Drug Utilization; Female; Follow-Up Studies; Humans; Inappropriate Prescribing; Logistic Models; Male; Middle Aged; Organometallic Compounds; Pakistan; Practice Patterns, Physicians'; Salicylates; Young Adult | 2019 |
Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Exanthema; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2018 |
Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
Topics: Adolescent; Adult; Antidiarrheals; Bismuth; Delayed-Action Preparations; Diarrhea; Dimethyl Fumarate; Double-Blind Method; Drug Therapy, Combination; Female; Flatulence; Healthy Volunteers; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds; Salicylates; Young Adult | 2018 |
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Cholera; Diarrhea; Disease Outbreaks; Emergency Medical Services; Feces; Female; Fluid Therapy; Haiti; Humans; Length of Stay; Male; Organometallic Compounds; Probiotics; Saccharomyces; Salicylates; Severity of Illness Index; Treatment Outcome; Vibrio cholerae | 2015 |
[The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Topics: Adolescent; Adult; Anti-Infective Agents; Bismuth; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Middle Aged; Organometallic Compounds; Propylamines; Prospective Studies; Treatment Outcome; Young Adult | 2008 |
Travellers' diarrhoea: prevention by chemoprophylaxis.
Topics: Adult; Bismuth; Clioquinol; Diarrhea; Drug Combinations; Drug Therapy, Combination; Furazolidone; Humans; Neomycin; Organometallic Compounds; Salicylates; Streptomycin; Sulfadiazine; Sulfamethazine; Sulfathiazoles; Travel | 1983 |
Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
Topics: Antidiarrheals; Bismuth; Diarrhea; Double-Blind Method; Escherichia coli Infections; Feces; Female; Humans; Male; Organometallic Compounds; Random Allocation; Salicylates; Travel | 1983 |
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).
Topics: Adult; Bismuth; Clinical Trials as Topic; Diarrhea; Escherichia coli Infections; Humans; Mexico; Organometallic Compounds; Salicylates; Travel; United States | 1980 |
The role of location of food consumption in the prevention of travelers' diarrhea in Mexico.
Topics: Bismuth; Diarrhea; Food Contamination; Food Microbiology; Humans; Mexico; Organometallic Compounds; Placebos; Restaurants; Salicylates; Travel; United States | 1980 |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine | 1997 |
One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Diarrhea; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tetracycline | 1997 |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anus Diseases; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hallucinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Omeprazole; Peptic Ulcer; Pregnancy; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Taste Disorders; Time Factors; Tongue Diseases; Treatment Outcome; Urea; Vomiting | 1998 |
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea.
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea; Double-Blind Method; Escherichia coli Infections; Humans; Infant; Organometallic Compounds; Rehydration Solutions; Retroviridae Infections; Salicylates | 2001 |
Which place for bismuth subsalicylate in the treatment of enteric infections?
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea; Gastroenteritis; Humans; Infant; Organometallic Compounds; Rehydration Solutions; Salicylates | 2001 |
One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Diarrhea; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exanthema; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Prospective Studies; Pruritus; Ranitidine; Tetracycline; Treatment Outcome; Vomiting | 2001 |
Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Drug Combinations; Dysentery, Bacillary; Escherichia coli Infections; Humans; Mexico; Placebos; Salicylates; Students | 1977 |
New remedy for traveler's diarrhea.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Humans; Mexico; Salicylates; Travel; United States | 1978 |
Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.
Topics: Acute Disease; Adult; Bismuth; Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Loperamide; Male; Nonprescription Drugs; Organometallic Compounds; Piperidines; Salicylates | 1990 |
Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy.
Topics: Aeromonas; Africa, Western; Animals; Bismuth; Cryptosporidium; Diarrhea; Entamoeba histolytica; Escherichia coli; Feces; Female; Giardia; Humans; Male; Mexico; Organometallic Compounds; Salicylates; Shigella; Specimen Handling; Travel | 1988 |
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
Topics: Adolescent; Adult; Bismuth; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Humans; Middle Aged; Organometallic Compounds; Salicylates | 1987 |
Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Patient Compliance; Salicylates; Salmonella enteritidis; Shigella dysenteriae; Tablets; Travel | 1986 |
Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.
Topics: Adult; Bismuth; Diarrhea; Humans; Mexico; Organometallic Compounds; Probability; Random Allocation; Salicylates; Tablets; Travel | 1987 |
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bismuth; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Diarrhea, Infantile; Drug Combinations; Dysentery, Amebic; Dysentery, Bacillary; Escherichia coli Infections; Giardiasis; Humans; Infant; Kaolin; Loperamide; Narcotics; Organometallic Compounds; Parasympatholytics; Pectins; Salicylates; Salmonella Infections; Travel | 1985 |
Prevention of traveler's diarrhea.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Enterotoxins; Escherichia coli; Escherichia coli Infections; Humans; Organometallic Compounds; Salicylates; Travel | 1985 |
Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea.
Topics: Acute Disease; Adult; Antidiarrheals; Bismuth; Diarrhea; Humans; Latin America; Loperamide; Organometallic Compounds; Piperidines; Salicylates; Travel; United States | 1986 |
47 other study(ies) available for bismuth and Diarrhea
Article | Year |
---|---|
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Topics: Aged, 80 and over; Anemia; Antidiarrheals; Betacoronavirus; Bismuth; Blood Sedimentation; C-Reactive Protein; Coronavirus Infections; Cough; COVID-19; Crohn Disease; Diarrhea; Humans; Lymphopenia; Male; Organometallic Compounds; Pandemics; Pneumonia, Viral; Salicylates; SARS-CoV-2; Treatment Outcome | 2020 |
74-Year-Old Woman With Chronic Diarrhea.
Topics: Aged; Antidiarrheals; Bismuth; Chronic Disease; Colitis, Microscopic; Diagnosis, Differential; Diarrhea; Female; Humans; Intestinal Mucosa; Organometallic Compounds; Salicylates | 2021 |
Bismuth salicylate for diarrhea in children.
Topics: Antidiarrheals; Bismuth; Child; Cost-Benefit Analysis; Developing Countries; Diarrhea; Evidence-Based Medicine; Humans; Organometallic Compounds; Reye Syndrome; Salicylates | 2013 |
[Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Taste Disorders; Treatment Outcome; Young Adult | 2015 |
[Topic: Treating travelers' diarrhea. When should medication be given?].
Topics: Adult; Anti-Bacterial Agents; Antidiarrheals; Atropine; Bismuth; Child; Cross-Sectional Studies; Diarrhea; Diphenoxylate; Drug Combinations; Dysentery; Fluid Therapy; Fluoroquinolones; Humans; Loperamide; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Travel | 2008 |
[Bismuth salt of sulfonamide in therapy of common diarrheas in children].
Topics: Bismuth; Child; Diarrhea; Humans; Infant; Sulfanilamide; Sulfanilamides; Sulfonamides | 1959 |
[The importance of bismuth silicate in pediatric therapeutics].
Topics: Antidiarrheals; Bismuth; Child; Diarrhea; Gastroenteritis; Humans; Infant; Silicates | 1960 |
[Clinical study of bismuth aluminum carbonate in pediatrics].
Topics: Aluminum; Antacids; Antidiarrheals; Bismuth; Carbonates; Child; Diarrhea; Diarrhea, Infantile; Gastroenterology; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Pediatrics | 1962 |
[THE EFFECTIVENESS OF STREPTOMYCIN-BISMUTH IN DIARRHEA IN CHILDREN].
Topics: Antacids; Antidiarrheals; Bismuth; Child; Diarrhea; Diarrhea, Infantile; Humans; Infant; Streptomycin | 1963 |
[INFANTILE DIARRHEA (1)].
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Child; Chloramphenicol; Colistin; Diarrhea; Diarrhea, Infantile; Drug Therapy; Humans; Infant; Lactates; Opium; Protein Synthesis Inhibitors; Tannins; Tetracycline | 1964 |
[TREATMENT OF DIARRHEA WITH A NEW INTESTINAL ANTISEPTIC].
Topics: Anti-Infective Agents, Local; Bismuth; Colitis; Diarrhea; Dysentery; Dysentery, Amebic; Humans; Nitrofurans | 1964 |
[COLONIC DIGESTIVE INSUFFICIENCY DUE TO PROLONGED DEPLETION OF THE FLORA, A LATE SEQUEL TO ANTIBIOTIC THERAPY].
Topics: Anti-Bacterial Agents; Bismuth; Colonic Diseases; Constipation; Diarrhea; Dietary Proteins; Digestion; Drug Therapy; Humans; Intestines; Toxicology; Vitamins | 1964 |
Can I prevent travelers' diarrhea by taking antibiotics before my trip?
Topics: Antibiotic Prophylaxis; Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 2006 |
[Therapy resistant diarrhea].
Topics: Bismuth; Cacao; Diarrhea; Humans; Silver; Tannins | 1967 |
Traveler's diarrhea: update 1983.
Topics: Bismuth; Child; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometallic Compounds; Premedication; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Prevention and treatment of "traveler's diarrhea".
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometallic Compounds; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Traveler's diarrhea.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1983 |
[Treatment of acute diarrhea in general practice. Therapeutic experiences with Karaya bismuth].
Topics: Acute Disease; Adolescent; Adult; Aged; Bismuth; Diarrhea; Female; Humans; Karaya Gum; Male; Middle Aged; Polysaccharides; Prospective Studies | 1983 |
Traveler's diarrhea in the Mediterranean basin.
Topics: Acute Disease; Adult; Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1980 |
Risk of hypercalcemia from prophylaxis of traveler's diarrhea.
Topics: Bismuth; Diarrhea; Humans; Hypercalcemia; Organometallic Compounds; Risk; Salicylates; Travel | 1983 |
Travelers' diarrhea.
Topics: Adult; Bismuth; Child; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1983 |
Traveler's diarrhea: must it spoil the patient's trip?
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Humans; Organometallic Compounds; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
How to avoid running with Escherichia coli.
Topics: Bismuth; Diarrhea; Escherichia coli Infections; Humans; Salicylates; Travel | 1980 |
Use of Pepto-Bismol in diarrhea.
Topics: Bismuth; Diarrhea; Drug Interactions; Humans; Salicylates | 1982 |
Travelers' diarrhea: recent advances in prophylaxis and treatment.
Topics: Bismuth; Diarrhea; Doxycycline; Fluid Therapy; Humans; Organometallic Compounds; Salicylates; Travel | 1982 |
Preventing traveler's diarrhea.
Topics: Bismuth; Diarrhea; Doxycycline; Humans; Organometallic Compounds; Salicylates; Travel | 1981 |
[Travellers' diarrhea].
Topics: Bismuth; Diarrhea; Humans; Salicylates; Travel | 1980 |
Bismuth preparations for diarrhea.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1980 |
Travelers' diarrhea. Epidemiology, prevention, and self-treatment.
Topics: Antidiarrheals; Bismuth; Diarrhea; Food Microbiology; Humans; Organometallic Compounds; Salicylates; Self Care; Travel; Water Microbiology | 1998 |
Clostridium difficile colitis associated with treatment of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Penicillins; Salicylates; Stomach Diseases | 1998 |
Microscopic colitis syndrome: lymphocytic colitis and collagenous colitis.
Topics: Adult; Bismuth; Chronic Disease; Colitis; Colonoscopy; Diagnosis, Differential; Diarrhea; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Organometallic Compounds; Pancreatic Neoplasms; Prognosis; Salicylates; Vipoma | 1999 |
Drug prophylaxis for travelers' diarrhea.
Topics: 4-Quinolones; Anti-Infective Agents; Antibiotic Prophylaxis; Bismuth; Diarrhea; Escherichia coli Infections; Humans; Organometallic Compounds; Probiotics; Salicylates; Travel | 2002 |
Travelers' diarrhea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Diarrhea; Humans; Hygiene; Travel; Water-Electrolyte Imbalance | 1979 |
The antidiarrheal action of bismuth subsalicylate in the mouse and the rat.
Topics: Animals; Antidiarrheals; Bismuth; Diarrhea; Disease Models, Animal; Male; Mice; Rats | 1975 |
For your information: traveler's diarrhea.
Topics: Bismuth; Diarrhea; Fluid Therapy; Food Microbiology; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology; Water Supply | 1991 |
Emporiatrics: diarrhea in travelers.
Topics: Bismuth; Campylobacter jejuni; Diarrhea; Dysentery, Bacillary; Food Contamination; Giardiasis; Humans; Organometallic Compounds; Rotavirus Infections; Salicylates; Salmonella Infections; Sulfonamides; Travel | 1990 |
Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
Topics: Acquired Immunodeficiency Syndrome; Antidiarrheals; Bismuth; Brain Diseases; Diarrhea; Humans; Intestinal Absorption; Male; Middle Aged; Myoclonus; Organometallic Compounds; Salicylates | 1990 |
Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni.
Topics: Animals; Animals, Newborn; Bismuth; Campylobacter fetus; Campylobacter Infections; Colony Count, Microbial; Diarrhea; Dose-Response Relationship, Drug; Female; Intestines; Male; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates | 1990 |
Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice.
Topics: Animals; Bismuth; Bone Marrow; Carcinoma, Ehrlich Tumor; Diarrhea; Doxorubicin; Drug Administration Schedule; Heart; Male; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Inbred ICR | 1988 |
Does bismuth subnitrate normalize intestinal conditions in patients with chronic diarrhea?
Topics: Aged; Antacids; Bismuth; Chronic Disease; Diarrhea; Female; Humans; Intestinal Obstruction | 1988 |
Pepto-Bismal efficacy studies for diarrhea. indication submitted to FDA.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates | 1986 |
Travelers' diarrhea. Controversy and consensus.
Topics: Antidiarrheals; Bismuth; Diarrhea; Doxycycline; Drug Combinations; Food; Humans; Organometallic Compounds; Risk; Salicylates; Sulfamethoxazole; Terminology as Topic; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccination | 1985 |
[Ganglioneuroblastoma and ulcerative colitis. Chance association].
Topics: Abdominal Neoplasms; Antineoplastic Agents; Bismuth; Charcoal; Child, Preschool; Colitis, Ulcerative; Diarrhea; Female; Ganglioneuroma; Humans; Sulfasalazine | 1974 |
[Letter: Functional diarrheae].
Topics: Bismuth; Calcium Carbonate; Diarrhea; Humans | 1974 |
[Treatment of constipation and colitis by the bismuth subnitrate--karaya gum association].
Topics: Adult; Aged; Bismuth; Colitis; Constipation; Diarrhea; Female; Humans; Male; Middle Aged; Nitrates; Resins, Plant | 1970 |
[Proposals for analytic methods for Italian National Formulary preparations. Antidiarrhea tablets].
Topics: Benzoates; Bismuth; Diarrhea; Gastrointestinal Agents; Humans; Methods; Naphthalenes; Tablets | 1967 |
[Clinical experimentation with Trisibam].
Topics: Bismuth; Diarrhea; Gastrectomy; Gastrointestinal Diseases; Humans; Magnesium; Peptic Ulcer; Postoperative Complications; Sodium | 1967 |